Advertisement

Aging Clinical and Experimental Research

, Volume 29, Supplement 1, pp 29–33 | Cite as

Management of concomitant hyperparathyroidism and thyroid diseases in the elderly patients: a retrospective cohort study

  • Alessandra Panarese
  • Vito D’Andrea
  • Stefano Pontone
  • Pasqualino Favoriti
  • Daniele Pironi
  • Stefano Arcieri
  • Angelo Filippini
  • Salvatore Sorrenti
Original Article
  • 126 Downloads

Abstract

Background

Thyroid disease and hyperparathyroidism are the most common endocrine disorders. The incidence of thyroid disease in patients with hyperparathyroidism ranges in the different series from 17 to 84%, and thyroid cancer occurs with an incidence ranging from 2 to 15%.

Aim

The aim of our study was to analyze the management of elderly patients with concomitant thyroid and parathyroid disease in order to define the best surgical therapeutic strategy and avoid reoperations associated with a higher risk of complications.

Methods

All consecutive patients (64 patients, age range 60–75 years), undergoing surgery for hyperparathyroidism, from January 2011 to June 2014, were retrospectively evaluated. Enrolled patients were divided into two study groups of patients affected by hyperparathyroidism with or without a concomitant thyroid disease.

Results

Out of 64 patients enrolled in our study (24 men, age range 60–75 years), affected by hyperparathyroidism, 34 had an associated thyroid disease and were treated with total thyroidectomy and parathyroidectomy. The group, who underwent parathyroidectomy associated with thyroidectomy, had no greater complications than the group receiving only parathyroidectomy.

Conclusions

Thyroid disease must be excluded in patients affected by hyperparathyroidism. It is difficult to determine whether hyperparathyroidism can be considered a risk factor for thyroid disease, but an accurate preoperative study is essential for a surgery able to treat both thyroid and parathyroid disease. In this way, we avoid the elderly patient, with associated morbidity and increased surgical risk, to undergo a reoperation for thyroid disease, burdened with major complications.

Keywords

Hyperparathyroidism Thyroid disease Parathyroidectomy Thyroidectomy 

Abbreviations

PHPT

Primary hyperparathyroidism

QPTH

Intraoperative parathyroid hormone assay

PH

Parathyroid hormone

US

Ultrasonography

CT

Computer tomography

MEN

Multiendocrine neoplasia

FNA

Fine-needle aspiration biopsy

Notes

Compliance with ethical standards

Conflict of interest

All authors listed have contributed sufficiently to the project to be included as authors, and to the best of our knowledge, no conflict of interest, financial or other exists.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Golden SH, Robinson KA, Saldanha I et al (2009) Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94:1853CrossRefPubMedGoogle Scholar
  2. 2.
    Kissin M, Bakst H (1947) Coexisting myxedema and hyperparathyroidism. J Clin Endocrinol Metab 7:152–158CrossRefPubMedGoogle Scholar
  3. 3.
    Ryan S, Courtney D, Timon C (2015) Co-existent thyroid disease in patients treated for primary hyperparathyroidism: implications for clinical management. Eur Arch Otorhinolaryngol 272:419–423CrossRefPubMedGoogle Scholar
  4. 4.
    Bentrem DJ, Angelos P, Talamonti MS et al (2002) Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism. Thyroid 12:1109–1112CrossRefPubMedGoogle Scholar
  5. 5.
    Strichartz SD, Guiliano AE (1990) The operative management of coexisting thyroid and parathyroid disease. Arch Surg 125:1327–1331CrossRefPubMedGoogle Scholar
  6. 6.
    Heizmann O, Viehl CT, Schmid R et al (2009) Impact of concomitant thyroid pathology on preoperative workup for primary hyperparathyroidism. Eur J Med Res 14:37–41PubMedPubMedCentralGoogle Scholar
  7. 7.
    Prinz RA, Barbato AL, Braithwaite SS et al (1982) Simultaneous primary hyperparathyroidism and nodular thyroid disease. Surgery 92:454–458PubMedGoogle Scholar
  8. 8.
    Monroe DP, Edeiken-Monroe BS, Lee JE et al (2008) Impact of preoperative thyroid ultrasonography on the surgical management of primary hyperparathyroidism. Br J Surg 95:957–960CrossRefPubMedGoogle Scholar
  9. 9.
    Zheng YX, Xu SM, Wang P et al (2007) Preoperative localization and minimally invasive management of primary hyperparathyroidism concomitant with thyroid disease. J Zhejiang Univ Sci B 8:626–631CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gul K, Ozdemir D, Korukluoglu B et al (2010) Preoperative and postoperative evaluation of thyroid disease in patients undergoing surgical treatment of primary hyperparathyroidism. Endocr Pract 16:7–13CrossRefPubMedGoogle Scholar
  11. 11.
    Sidhu S, Campbell P (2000) Thyroid pathology associated with primary hyperparathyroidism. Aust N Z J Surg 70:285–287CrossRefPubMedGoogle Scholar
  12. 12.
    Kösem M, Algün E, Kotan C et al (2004) Coexistent thyroid pathologies and high rate of papillary cancer in patients with primary hyperparathyroidism: controversies about minimal invasive parathyroid surgery. Acta Chir Belg 104:568–571CrossRefPubMedGoogle Scholar
  13. 13.
    Masatsugu T, Yamashita H, Noguchi S et al (2005) Significant clinical differences in primary hyperparathyroidism between patients with and those without concomitant thyroid disease. Surg Today 35:351–356CrossRefPubMedGoogle Scholar
  14. 14.
    Murray SE, Sippel RS, Chen H (2012) Incidence of concomitant hyperparathyroidism in patients with thyroid disease requiring surgery. J Surg Res 178:264–267CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Sianesi M, Del Rio P, Arcuri MF et al (2003) Hyperparathyroidism associated with thyroid pathology. Am J Surg 185:58–60CrossRefPubMedGoogle Scholar
  16. 16.
    Del Rio P, Arcuri MF, Bezer L et al (2009) Association between primary hyperparathyroidism and thyroid disease. Role of preoperative PTH. Ann Ital Chir 80:435–438PubMedGoogle Scholar
  17. 17.
    Katz AD, Kong LB (1992) Incidental preclinical hyperparathyroidism identified during thyroid operations. Am Surg 58:747–749PubMedGoogle Scholar
  18. 18.
    Wagner B, Begic-Karup S, Raber W et al (1999) Prevalence of primary hyperparathyroidism in 13387 patients with thyroid diseases, newly diagnosed by screening of serum calcium. Exp Clin Endocrinol Diabetes 107:457–461CrossRefPubMedGoogle Scholar
  19. 19.
    Catania A, Sorrenti S, Falvo L et al (2002) Validity and limits of intraoperative rapid parathyroid hormone assay in primary hyperparathyroidism treated by traditional and mini-invasive surgery. Int Surg 87:226–232PubMedGoogle Scholar
  20. 20.
    Romani AM, Panarese A, La Torre V et al (2007) The role of intraoperative parathyroid hormone assay in the surgical management of hyperparathyroidism. Ann Ital Chir 78:91–96PubMedGoogle Scholar
  21. 21.
    Irvin GL, Deriso GT (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468CrossRefPubMedGoogle Scholar
  22. 22.
    Thompson GB, Grant CS, Perrier ND et al (1999) Reoperative parathyroid surgery in the era of sestamibi scanning and intraoperative parathyroid hormone monitoring. Arch Surg 134:699–704; discussion 704–5Google Scholar
  23. 23.
    Chou F-F, Lee C-H, Chen J-B et al (2002) Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidism. Arch Surg 137:341–344CrossRefPubMedGoogle Scholar
  24. 24.
    Cantisani V, Grazhdani H, Ricci P et al (2014) Q-elastosonography of solid thyroid nodules: assessment of diagnostic efficacy and interobserver variability in a large patient cohort. Eur Radiol 24:143–150CrossRefPubMedGoogle Scholar
  25. 25.
    Smith MA, Mc Henry C, Oslapas R et al (1989) Altered TSH levels associated with increased serum 1,25-dihydroxyvitamin D3: a possible link between thyroid and parathyroid disease. Surgery 106:987–991PubMedGoogle Scholar
  26. 26.
    Kutlay S, Atli T, Koseogullari O et al (2005) Thyroid disorders in hemodialysis patients in an iodine-deficient community. Artif Organs 29:329–332CrossRefPubMedGoogle Scholar
  27. 27.
    Falvo L, Catania A, Sorrenti S et al (2004) Prognostic significance of the age factor in the thyroid cancer: statistical analysis. J Surg Oncol 88:217–222CrossRefPubMedGoogle Scholar
  28. 28.
    Baldini E, Tuccilli C, Prinzi N et al (2015) Deregulated expression of aurora kinases is not a prognostic biomarker in papillary thyroid cancer patients. PLoS ONE 10:25Google Scholar
  29. 29.
    Lin SY, Lin WM, Lin CL et al (2014) The relationship between secondary hyperparathyroidism and thyroid cancer in end stage renal disease: a population based cohort study. Eur J Intern Med 25:276–280CrossRefPubMedGoogle Scholar
  30. 30.
    Wang TS, Roman SA, Cox H et al (2009) The management of thyroid nodules in patients with primary hyperparathyroidism. J Surg Res 154:317–323CrossRefPubMedGoogle Scholar
  31. 31.
    Pironi D, Pontone S, Vendettuoli M et al (2014) Prevention of complications during reoperative thyroid surgery. Clin Ter 165:e285–e290PubMedGoogle Scholar
  32. 32.
    Tartaglia F, Blasi S, Tromba L et al (2011) Duplex ultrasound and magnetic resonance imaging of the supra-aortic arches in patients with non recurrent inferior laryngeal nerve: a comparative study. G Chir 32:245–250PubMedGoogle Scholar
  33. 33.
    Calò PG, Pisano G, Medas F et al (2013) Intraoperative recurrent laryngeal nerve monitoring in thyroid surgery: is it really useful? Clin Ter 164:e193–e198PubMedGoogle Scholar
  34. 34.
    Tartaglia F, Salvatori FM, Russo G et al (2011) Selective embolization of thyroid arteries for preresection or palliative treatment of large cervicomediastinal goiters. Surg Innov 18:70–78CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Alessandra Panarese
    • 1
  • Vito D’Andrea
    • 1
  • Stefano Pontone
    • 1
  • Pasqualino Favoriti
    • 1
  • Daniele Pironi
    • 1
  • Stefano Arcieri
    • 1
  • Angelo Filippini
    • 1
  • Salvatore Sorrenti
    • 1
  1. 1.Department of Surgical Sciences, Policlinico Umberto I“Sapienza” University of RomeRomeItaly

Personalised recommendations